Category:
Anti-tumor Preparations
Standard:
N;
It is an orally bioavailable, small-molecule receptor tyrosine kinase inhibitor.
Strength: 0.25g; 0.375g; 0.425g
CFDA approved.
Apatinib Mesylate Tablets are solid oral dosage forms containing apatinib mesylate as the active pharmaceutical ingredient. Manufactured via high-precision compression technology, these tablets feature uniform dissolution rates and strict chemical stability controls to ensure consistent bioavailability in clinical settings.